/CMRC

CMRC

CMRC

$3.51USD↑+13.80%+0.42 today

MARKET CAP

290.4M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$3 – $4

52W RANGE

$2

$6

AI Summary

Stalk

TrimMedium

CMRC is in a confirmed Stage 4 decline with long- and medium-term downtrends validated by active bearish patterns and moving average resistance. Short-term price is extended below key EMAs, limiting immediate selling opportunity and favoring deferral of new short exposure into potential pullbacks. Medium-term bias remains bearish, guided by support failure and pivot breakdown, while long-term structural downtrend persists.

↑Q2 2026 revenue $84.5M (+14% YoY), driven by GMV growth to $8.8B.
↑Non-GAAP operating income $8.1M, surpassing guidance and indicating cost discipline.
↓Analysts cut revenue guidance by $18M at midpoint, citing cautious bookings outlook.

Full analysis →

Buying

4

institutions

Selling

5

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	5.52 M	16.34 M	+757.15 K	+28.5%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	2.36 M	6.98 M	+739.67 K	+61.5%	0.00%
RT Renaissance Technologies LLC Q2 2026	SELL	1.24 M	3.66 M	+-14.30 K	+9.6%	0.01%
MG Man Group Plc Q2 2026	BUY	425.67 K	1.26 M	+372.72 K	+791.2%	0.00%
CA Citadel Advisors LLC Q2 2026	SELL	197.78 K	585.42 K	+-248.52 K	-50.9%	0.00%
JC Jpmorgan Chase & Co Q2 2026	BUY	31.78 K	96.30 K	+4.64 K	+38.0%	0.00%
PA Point72 Asset Management, L.P. Q2 2026	SELL	17.68 K	52.34 K	+-250.46 K	-92.7%	0.00%
MM Millennium Management LLC Q2 2026	SELL	0.00	0.00	+-250.20 K	-100.0%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	SELL	0.00	0.00	+-17.57 K	-100.0%	0.00%